期刊文献+

超声心动图及B型脑钠肽与左心室舒张期压力的相关性及受试者工作特征曲线评价 被引量:4

Combining echocardiography and B-type natriuretic peptide in evaluation of left ventricular filling pressures with receiver-operating characteristic(ROC) analysis
下载PDF
导出
摘要 目的应用受试者工作特征(ROC)曲线分析左心室舒张末期压力(LVEDP)及舒张早期经二尖瓣口血流速度与舒张早期二尖瓣环的运动速度比值(E/Ea)、B型脑钠肽(BNP)的关系。方法收集疑有冠心病行选择性冠状动脉造影检查104例患者进行LVEDP测定,并行多普勒超声心动图检查和BNP测定。分析上述指标的相关性及ROC曲线特征。根据美国纽约心脏病协会(NYHA)的标准对心脏的患者进行心功能分级。结果 104例患者中,86例有器质性心脏病(心功能Ⅰ级及Ⅱ级各18例,心功能Ⅲ级21例,心功能Ⅳ级29例),另18例无明显的心脏病证据。随着心功能分级的增加,LVEDP、BNP及E/Ea比值呈不同程度进行性的恶化。LVEDP与BNP和E/Ea呈正相关(r=0.786,0.651,均P<0.01),与E/A和Ea/Aa呈负相关(r=-0.231,-0.652,P<0.05或<0.01)。E/Ea及BNP的ROC曲线下面积分别为0.830及0.951(均P<0.01)。结论 E/Ea比值及BNP能较好地无创性评估LVEDP,但BNP的准确度更高。 Objective To explore the relation between left ventricular end-diastolic pressure(LVEDP) with the ratio of transmitral early diastolic velocity/mitral annular early diastolic velocity(E/Ea ratio) and B-type natriuretic peptide(BNP) by receiver-operating characteristic(ROC) analysis.Methods One-hundred and four patients who were suspected coronary artery disease experienced selected artery angiography,and LVEDP was measured meanwhile.They underwent a thorough Doppler-echocardiographic and pulsed tissue-Doppler study and BNP measurement to noninvasively estimate LVEDP.The correlation and ROC curves were analyzed.The functional assessment of the heart failure in patients adopted the New York Heart Association(NYHA) classification.Results A total of 86 patients had organic heart diseases(18 patients with class Ⅰ of NYHA,18 with class Ⅱ,21 with class Ⅲ and 29 with class Ⅳ) and the remaining 18 patients had no obvious evidence of heart disease.With the progression of the functional classification,LVEDP,BNP and E/Ea ratio showed different exacerbation.LVEDP had positive correlation with BNP and E/Ea ratio(r=0.786,0.651,both P0.01),but negative correlation with E/A and Ea/Aa(r=-0.231,-0.652,P0.05 or 0.01).The areas under the ROC curves for E/Ea ratio and BNP were 0.830,0.951,respectively(P0.01).Conclusion LVEDP level can be determined by noninvasive methods of E/Ea ratio and BNP level.The accuracy was better by level of BNP than by E/Ea ratio.
出处 《临床荟萃》 CAS 2011年第6期465-468,共4页 Clinical Focus
基金 河北省卫生厅2010年医学科学研究重点课题(20100261)
关键词 冠状动脉疾病 超声心动描记术 利钠肽 coronary disease echocardiography natriuretic peptide brain
  • 相关文献

参考文献11

  • 1Zou KH, O Malley AJ, Mauri L. Receiver-operatingcharacteristic analysis for evaluating diagnostic tests andpredictive models[J]. Circulation, 2007,115 (5) : 654-657.
  • 2Jessup M, Abraham WT, Casey DE, et al. 2009 FocusedUpdate: ACCF/AHA Guidelines for the Diagnosis andManagement of Heart Failure in Adults: a Report of theAmerican College of Cardiology Foundation/American HeartAssociation Task Force on Practice Guidelines: Developed inCollaboration With the International Society for Heart andLung Transplantation [J]. Circulation, 2009, 119 ( 14 ) : 1977-2016.
  • 3Mottram PM,Marwick TH. Assessment of diastolic function:what the general cardiologist needs to know[J]. Heart, 2005,91(5): 681-695.
  • 4Ommen SR,Nishimura RA,Appleton CP, et al. Clinical utilityof Doppler echocardiography and tissue Doppler imaging in theestimation of left ventrieular filling pressures: a comparativesimultaneous Doppler catheterization study [J ]. Circulation,2000,102(15),1788-1794.
  • 5Hillis GS,Moller JE,Pellikka PA,et al. Noninvasive estimationof left ventricular filling pressure by E/e is a powerfulpredictor of survival after acute myocardial infarction[J]. J AmColl Cardiol,2004,43(3) :360-367.
  • 6Dokainish H, Zoghbi WA, Lakkis NM, et al. Optimalnoninvasive assessment of left ventricular filling pressures: acomparison of tissue Doppler echocardiography and B-typenatriuretic peptide in patients with pulmonary artery catheters[J], Circulation, 2004,109 (20) : 2432-2439.
  • 7Dokainish H. Combining tissue Doppler ecbocardiography andB-type natriuretic peptide in the evaluation of left ventricularfilling pressures: Review of the literature and clinicalrecommendations[J]. Can J Cardiol, 2007,23 (12) : 983-989.
  • 8Arnold MO, Howlett JG, Dorian P, et al. CanadianCardiovascular Society Consensus Conferencerecommendations on heart failure update 2007: Prevention,management, during intereurrent illness acutedecompensation,and use of biomarkers [J]. Can J Cardiol,2007,23(1): 21-45.
  • 9Mant D, Hobbs FDR, Glasziou P, et al. Identification andguided treatment of ventricular dysfunction in general practiceusing blood B-type natriuretie peptide [J]. Br J Gen Pract,2008,58(551): 393-399.
  • 10Bibbins-Domingo K, Ansari M, Schiller NB, et al. Is B-typenatriuretic peptide a useful screening test for systolic ordiastolic dysfunction in patients with coronary disease? Datafrom the Heart and Soul Study[J]. Am J Med,2004,116(8):509-516.

二级参考文献11

  • 1郭攀,黄振文,卢长青.B型钠尿肽与心功能不全严重程度及近期愈后的关系探讨[J].河南医学研究,2005,14(3):208-210. 被引量:7
  • 2林营.心力衰竭患者BNP的临床价值[J].海南医学院学报,2005,11(6):512-514. 被引量:4
  • 3朱红俊,龚少愚,邹逊,魏慧渊,陆曙.心力衰竭病因对血浆BNP水平的影响[J].临床荟萃,2007,22(1):27-28. 被引量:25
  • 4张拥军,郭静霞,郭丽.脑钠肽临床应用研究进展[J].临床荟萃,2007,22(8):601-603. 被引量:11
  • 5陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:35-38.
  • 6Ishii J, Nomura M, Nakamura Y,et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure[J]. Am J Cardiol,2002,89(2) :691-695.
  • 7Davis M, Espiner E oRichards G, et al. Plasma brain natriuretie peptide in assessment of acute dyspnea[J]. Lancet, 1994,343 (8895) : 440-444.
  • 8Chen HH, Burnett JC. Natriuretic peptides in the pathophysiology of congestive heart failure[J]. Curr Cardiol Rep. 2000,2(3) : 198-205.
  • 9Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventuicular dysfunction and heart failure :a multicenter evaluation[J]. Am Heart,2002,144(5) :834-839.
  • 10Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease[J]. Clin Sci, 1998,95(5) :519-529.

共引文献3

同被引文献37

  • 1Kubo SH, Walter BA, John DH, et al. Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics[J]. Arch Intern Med, 1987,147(7) : 1227-1230.
  • 2Allen LA, Felker GM, Pocock S, et al. Liver function abnormalities and outcome in patients with chronic hear failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program[J]. Eur J Heart Fail,2009,11(2) :170-177.
  • 3van Deursen VM, Damman K, Hillege HL, et al. Abnormal liver function in relation to hemodynamic profile in heart failure patients[J]. J Card Fail, 2010,16 ( 1 ) : 84-90.
  • 4Shinagawa H, Inomata T, Koitabashi T, et al. Prognostic significance of serum bilirubin levels coincident with cardiac decompensation in chronic heart failure[J]. Circ J, 2008,72 (3) : 364-369.
  • 5Song BG,Jeon EU, Kim YH, et al. Correlation between levels of N-terminal pro-B-type natriuretic peptide and degrees of heart failure[J]. Korean J Intern Med, 2005,20 (1) : 26-32.
  • 6Groenning BA, Raymond I, Hildebrandt PR, et al Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population[J].Heart, 2004,90(3) :297-303.
  • 7Tschope C, Kasner M, Westermann D, et al. The role of NTproBNP in the diagnostics of isolated diastolic dysfunction.. correlation with echocardiographic and invasive measurements [J]. Eur Heart J,2005,26(21) :2277-2284.
  • 8无.肺动脉高压筛查诊断与治疗专家共识[J].中华心血管病杂志,2007,35(11):979-987. 被引量:268
  • 9MADHOK V,FALK G,ROGERS A. The accuracy of symptoms,signs and diagnostic tests in the diagnosis of left ventricular dysfunction in primary care:a diagnostic accuracy systematic review[J].BMC Family Practice,2008.56.
  • 10MAISEL A. Biomonitoring and biomarker-guided therapy:the next step in heart failure and biomarker research[J].Journal of the America College of Cardiology,2011,(18):1890-1892.

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部